Search Results - I. M. Marusenko

Refine Results
  1. 1

    RESULTS OF AN OPEN CLINICAL STUDY OF THE EFFICACY OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS by I M Marusenko

    Published 2009-06-01

    Objective: To evaluate the efficacy of leflunomide versus methotrexate in patients with rheumatoid arthritis. Subjects and methods. The study included 24 patients receiving leflunomide who underwent the determination of changes in the articular syndrome: the Ritchie index, the number of tender and s...

    Full description

    Get full text
    Article
  2. 2
  3. 3

    HYPERTHYROIDISM AND ATRIAL FIBRILLATION by I. M. Marusenko, E. G. Petrova

    Published 2017-07-01

    Review on a problem of the development of atrial fibrillation in patients with thyrotoxicosis is presented. Thyrotoxicosis is one of the most frequent endocrine diseases, conceding only to a diabetes mellitus. The most frequent reasons of hyperthyroidism are Graves’ disease and functional thyroid au...

    Full description

    Get full text
    Article
  4. 4

    The efficacy of the interleukin 17 inhibitor ixekizumab in psoriatic arthritis: data from real clinical practice by I. M. Marusenko, O. N. Sakovich

    Published 2021-06-01

    The article describes the peculiarities of drug provision for patients with psoriatic arthritis (PsA) in the Republic of Karelia. We present a clinical case of effective treatment with interleukin 17 inhibitor ixekizumab (IXE) in a randomized clinical trial and real clinical practice in a patient wi...

    Full description

    Get full text
    Article
  5. 5

    Features of diagnosis and treatment of anemic syndrome in patients with rheumatoid arthritis by N V Koryakova, N N Vesikova, I M Marusenko

    Published 2009-12-01

    Features of diagnostics and course of anemic syndrome in rheumatoid arthritis patients Objective. To study features of anemic syndrome in rheumatoid arthritis (RA) pts, to estimate influence of disease modifying anti – rheumatic drug therapy efficacy on the course of anemic syndrome. Material and me...

    Full description

    Get full text
    Article
  6. 6

    Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis by I. M. Marusenko, N. N. Vezikova, S. N. Kondrichin, N. D. Silvestrov

    Published 2019-03-01

    The article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasi...

    Full description

    Get full text
    Article
  7. 7

    Diabetes mellitus in patients with rheumatoid arthritis in the Republic of Karelia by N. V. Koryakova, I. I. Polskaya, I. M. Marusenko, T. I. Kulagina

    Published 2020-05-01

    Objective: to estimate the incidence of diabetes mellitus (DM) in patients with rheumatoid arthritis (RA) in the Republic of Karelia and to analyze the types of carbohydrate metabolism disorders.Patients and methods. The investigation enrolled 889 patients aged 18 years and older with RA treated in...

    Full description

    Get full text
    Article
  8. 8

    OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT by I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova

    Published 2017-09-01

    Aim. To study the prevalence of metabolic syndrome (MS) and total risk of cardiovascular diseases (CVD) in patients with gout depending on the presence of MS.Material and methods. 56 patients (aged 53.3±10.9 years; men 82%) with verified primary chronic gout [median disease duration 5.7 (2.0-8.5) ye...

    Full description

    Get full text
    Article
  9. 9
  10. 10

    Structum (chondroitin sulfate) in treatment of osteoarthritis by O J Varga, V K Ignatjev, N N Vesikova, I M Marusenko

    Published 2003-02-01

    Objective. To assess Structum (chondroitin sulfate) efficacy in treatment of osteoarthritis in Republic of Karelia. Methods. 34 pts with osteoarthritis (mean disease duration 6,44±0,67 years) were included. Functional Leken score (FLS), pain at rest and at walk on visual analog scale (VAS), pts nons...

    Full description

    Get full text
    Article
  11. 11

    Prevalence of rheumatic diseases TOC \o "1-5" \h \z in Karelia Repablic by N N Vesikova, W K Ignatiev, I M Marusenko, O. Yu. Varga

    Published 2003-04-01

    Цель. Анализ распространенности ревматоидного артрита (РА) и остеоартроза (ОА) в Республике Карелия (РК). Результаты. В 2000 г по сравнению с 1998 и 1999 гг. в РК выявлен рост обшей заболеваемости болезнями костно-мышечной системы. Однако показатели общей заболеваемости были более низкими по сравнен...

    Full description

    Get full text
    Article
  12. 12

    Rheumatoid arthritis and bacterial infections by N L Prokopjeva, N N Vesikova, I M Marusenko, V A Ryabkov

    Published 2008-02-01

    To study features of bacterial infections course in pts with rheumatoid arthritis (RA) and changes of laboratory measures after focus of infection sanation. Material and methods. 46 pts with definite rheumatoid arthritis were examined at the time of comorbid infection (Cl) detection and after infect...

    Full description

    Get full text
    Article
  13. 13
  14. 14

    ASSOCIATION OF rs4537545 (C>T) ALLELE POLYMORPHISM IN THE IL6R GENE WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS by L. V. Topchieva, I. E. Malysheva, O. V. Balan, I. M. Marusenko, O. Yu. Barysheva

    Published 2020-06-01

    Objective: to analyze the association of the polymorphic marker rs4537545 (C>T) in the IL6R gene with the development of rheumatoid arthritis (RA) in the population of the Republic of Karelia. Subjects and methods. The investigation included 190 samples of DNA extracted from the whole blood o...

    Full description

    Get full text
    Article
  15. 15

    CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME by I. S. Skopec, N. N. Vezikova, I. M. Marusenko, O. Yu. Barysheva, A. V. Malafeev, A. N. Malygin

    Published 2016-05-01

    Actuality of cardiovascular diseases today determines the high interest to study pathogenesis of atherosclerosis and to searching new risk factors which could help to optimize primary and secondary prevention. Study the correlation between biomarkers of inflammation and traditional risk factors (TRF...

    Full description

    Get full text
    Article
  16. 16

    Rheumatoid arthritis in real clinical practice. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-I») project by V. N. Amirdzhanova, E. Yu. Pogozheva, A. E. Karateev, R. R. Samigullina, O. B. Nesmeyanova, A. I. Kulikov, O. V. Antipova, E. V. Kryukova, I. G. Bannikova, I. M. Patrikeeva, A. I. Dubikov, R. G. Kamalova, I. B. Vinogradova, R. G. Mukhina, I. M. Marusenko

    Published 2019-05-01

    Objective: to describe the portrait of a patient with rheumatoid arthritis (RA) in real clinical practice, to assess disease activity from the point of view of a physician and a patient, functional status, quality of life (QOL), and the efficiency of the therapy performed.Patients and methods. The i...

    Full description

    Get full text
    Article
  17. 17

    THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY) by E. L. Nasonov, E. V. Zonova, O. N. Ivanova, L. A. Knyazeva, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko, O. B. Nesmeyanova, T. V. Plaksina, A. E. Sizikov, D. G. Krechikova, N. A. Petrochenkova, Yu. S. Shapovalova, N. S. Soroka, S. I. Pimanov, A. M. Pristrom, E. V. Kunder, E. V. Chernyaeva, A. V. Eremeeva, R. Ivanov

    Published 2016-12-01

    The article considers the results of an international multicenter randomized clinical trial of the efficacy and safety of the brand-name drug rituximab (MabThera), a monoclonal antibody against CD20 antigen of B cells, and its biosimi-lar drug (Acellbia®) (the BIORA study) in patients with rheumatoi...

    Full description

    Get full text
    Article
  18. 18

    A very early clinical response to treatment with the Janus kinase inhibitor tofacitinib in patients with active rheumatoid arthritis: the dynamics of pain and central sensitization... by A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova, E. V. Kalinina

    Published 2020-05-01

    Janus kinase (JK) inhibitors block the intracellular signaling pathways that are responsible for the synthesis of proinflammatory cytokines and mediators, which in turn cause the activation of pain receptors and central sensitization (CS). It is suggested that JK inhibitors can rapidly eliminate pai...

    Full description

    Get full text
    Article
  19. 19

    THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL by V G Barskova, Maksim Sergeyevich Eliseyev, I S Denisov, M E Eliseyeva, O A Belikov, G R Fadiyenko, F S Zharskaya, O P Polkovnikova, A N Kalyagin, M V Sklyanova, E A Shvetsova, L A Knyazeva, I M Marusenko, S E Myasoedova, E A Kozhevnikova, M N Petrova, T A Raskina, M V Koroleva, V V Tyrenko, A A Al-Nuvairakh, A G Khanov

    Published 2012-12-01

    Objective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (86.2%) men and 314 (13.8%) women, from 12 independe...

    Full description

    Get full text
    Article
  20. 20